DexCom, Inc.
DXCMNASDAQHealthcare · Surgical & Medical Instruments & Apparatus
Market cap
$23.78B
Employees
11,100
Exchange
NASDAQ
Headquarters
SAN DIEGO, CA
About DexCom, Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
DXCM news
DexCom, a leading continuous glucose monitoring technology company, has unveiled its strategic growth vision through 2030, outlining plans to expand market reach and enhance its product portfolio. The company aims to capitalize on the growing diabetes management market and increasing adoption of digital health solutions. DexCom's forward-looking roadmap demonstrates confidence in sustained revenue growth and market leadership.
Benzinga · May 15, 2026